Journal article
Endovascular Therapy of the Superficial Femoral Artery Via a Stand-Alone Transradial Access: A Single-Center Experience
Vascular and endovascular surgery, Vol.52(2), pp.107-114
02/01/2018
DOI: 10.1177/1538574417742239
PMID: 29179651
Abstract
Objective: We describe our experience in transradial recanalization of the superficial femoral artery (SFA), and we provide a stepwise approach accounting for the patient's height and optimizing the yield of currently available devices.
Methods and Results: Fifteen patients with simple SFA disease, including 4 patients with total SFA occlusions <15 cm, were selected for stand-alone transradial recanalization. A 6F, 125-cm multipurpose guiding catheter was used to cannulate the limb of interest and support device delivery. The procedure was successful in all patients and consisted of balloon angioplasty (using 0.014, 200-cm shaft monorail balloons) in all patients, and orbital atherectomy in 6 patients. We illustrate the steps and challenges of the transradial approach, namely the limited support in complex disease and the limited reach of current equipment.
Conclusion: In patients with simple SFA disease, transradial recanalization appears feasible and safe but currently limited to balloon angioplasty +/- orbital atherectomy. Proximal SFA stenting may be feasible in patients <160 cm in height.
Details
- Title: Subtitle
- Endovascular Therapy of the Superficial Femoral Artery Via a Stand-Alone Transradial Access: A Single-Center Experience
- Creators
- Elias B. Hanna - Louisiana State UniversityBashar A. Ababneh - Louisiana State UniversityAmit N. Amin - Louisiana State University
- Resource Type
- Journal article
- Publication Details
- Vascular and endovascular surgery, Vol.52(2), pp.107-114
- Publisher
- Sage
- DOI
- 10.1177/1538574417742239
- PMID
- 29179651
- ISSN
- 1538-5744
- eISSN
- 1938-9116
- Number of pages
- 8
- Language
- English
- Date published
- 02/01/2018
- Academic Unit
- Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984359914102771
Metrics
9 Record Views